Status:
TERMINATED
Motivational Interviewing
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Essential Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this project is to study ways to make it more likely that patients will take their blood pressure medicine as recommended by their doctors.
Detailed Description
The objective of this randomized control trial is to evaluate, among 190 African-American patients with poorly controlled hypertension followed in a community-based primary care practice, whether moti...
Eligibility Criteria
Inclusion
- The target population consisted of hypertensive African American patients who fulfilled the following eligibility criteria:
- Self-identification as African American
- Age 18 years or older
- Diagnosis of hypertension utilizing ICD-9 codes 401-401.9 (the code for essential hypertension)
- Taking at least one antihypertensive medication
- Uncontrolled hypertension of a clinic blood pressure reading \>140/90 mm Hg or 130/80 mm Hg (for those with kidney disease or diabetes) on two successive clinic visits prior to screening (defined per JNC VI criteria)
- Fluent in English language
Exclusion
- Participants were excluded if they:
- Had a diagnosis of cognitive impairment or serious medical condition as determined by their primary physician
- Were unable to give informed consent
- Refused to participate
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT00208104
Start Date
July 1 2002
End Date
September 1 2008
Last Update
February 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032